ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
13.35
-1.52 (-10.22%)
At close: Nov 2, 2026, 4:00 PM EST
13.35
0.00 (0.00%)
After-hours: Nov 2, 2026, 7:30 PM EST
ArriVent BioPharma Market Cap
ArriVent BioPharma has a market cap or net worth of $658.26 million as of November 2, 2026. It is the 11,806th most valuable company in the world and the 2,453rd biggest in the United States. Its market cap has decreased by 13.37% in one year.
Market Cap
658.26M
Enterprise Value
285.49M
1-Year Change
-13.37%
Global Rank
Country Rank
#2,453 United States
Category
ChartMarket Cap Chart
Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has increased from $575.22M to $658.26M, an increase of 14.44%. That is a compound annual growth rate of 4.99%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 658.26M | -20.75% |
| Dec 31, 2025 | 830.58M | -7.48% |
| Dec 31, 2024 | 897.69M | 56.06% |
| Jan 26, 2024 | 575.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Helus Pharma | 774.07M |
| Sana Biotechnology | 769.36M |
| Annexon | 767.80M |
| Ardelyx | 755.04M |
| Ginkgo Bioworks Holdings | 754.88M |
| OmniAb | 745.35M |
| Wave Life Sciences | 708.05M |
| Sagimet Biosciences | 703.41M |